Literature DB >> 19362679

Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.

Feng Wang1, Lagen Wan, Caicheng Zhang, Xiaofeng Zheng, Junming Li, Zhonghua Klaus Chen.   

Abstract

CD4(+)CD25(+) regulatory T cells (Tregs) are considered to play a key role as suppressors of immune-mediated reactions. The mechanisms of this suppression in animals and patients with autoimmune, allergic or oncogenic diseases have been investigated under various conditions. However, the precise mode of suppression by CD4(+)CD25(+) Tregs is still not clear. In this report, Tim-3-Galectin-9 pathway was explored as one of the mechanisms for the suppression and cytotoxicity induced by Tregs. Here, we demonstrated that Galectin-9 was expressed on CD4(+)CD25(+) Tregs by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Interestingly, blocking Tim-3-Galectin-9 pathway resulted in an obvious decreased suppression activity of Tregs and enhanced Th1 cytokine level in vitro. Furthermore, blocking Tim-3-Galectin-9 pathway negated prolonged survival of allogeneic skin grafts induced by CD4(+)CD25(+) Tregs in vivo. Our results suggest that Tim-3-Galectin-9 pathway involves the function of CD4(+)CD25(+) Tregs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19362679     DOI: 10.1016/j.imbio.2008.10.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  46 in total

Review 1.  Association of HLA-alleles with the immune regulation of chronic viral infections.

Authors:  Shokrollah Elahi; Helen Horton
Journal:  Int J Biochem Cell Biol       Date:  2012-05-14       Impact factor: 5.085

2.  Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.

Authors:  Chuan Wu; Theresa Thalhamer; Rafael F Franca; Sheng Xiao; Chao Wang; Chie Hotta; Chen Zhu; Mitsuomi Hirashima; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunity       Date:  2014-07-24       Impact factor: 31.745

3.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

4.  A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.

Authors:  John A Mengshol; Lucy Golden-Mason; Tomohiro Arikawa; Maxwell Smith; Toshiro Niki; Ryan McWilliams; Jessica A Randall; Rachel McMahan; Michael A Zimmerman; Manu Rangachari; Evgenia Dobrinskikh; Pierre Busson; Stephen J Polyak; Mitsuomi Hirashima; Hugo R Rosen
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 5.  Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.

Authors:  Li-Sha Cheng; Yun Liu; Wei Jiang
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

6.  Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.

Authors:  Manoj Kumar Tembhre; Anita Singh Parihar; Alpana Sharma; Somesh Gupta; Parthaprasad Chattopadhyay; Vinod Kumar Sharma
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

7.  Protective HIV-specific CD8+ T cells evade Treg cell suppression.

Authors:  Shokrollah Elahi; Warren L Dinges; Nicholas Lejarcegui; Kerry J Laing; Ann C Collier; David M Koelle; M Juliana McElrath; Helen Horton
Journal:  Nat Med       Date:  2011-07-17       Impact factor: 53.440

8.  Dexamethasone reduces IL-17 and Tim-3 expression in BALF of asthmatic mice.

Authors:  Xiao-Xia Lu; Karen S McCoy; Wei-Kun Hu; Jia-Li Xu; Hai-Qin Wang; Peng Chen; He-Bin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

Review 9.  TIM-3 as a new therapeutic target in systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Ning Zhang; Wen-Xian Li; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

10.  Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia.

Authors:  Ning-ning Shan; Yu Hu; Xin Liu; Xin Wang; Dai Yuan; Ying Li
Journal:  J Clin Immunol       Date:  2013-01-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.